FMFlora Elisa Cabello Montoya

Flora Elisa Cabello Montoya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Flora Elisa Cabello Montoya has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Natriuresis level as a marker of the diuretic therapy effectiveness and a predictor of an adverse outcome in patients with acute decompensated chronic heart failure

    by Zh. D. Kobalava, V. V. Tolkacheva, R. T. Andriamanohery, S. G. Kornilov, D. B. Akhmedova, A. A. Abramov, F. E. Cabello Montoya, A. A. Lapshin, Ж. Д. Кобалава, В. В. Толкачева, et al.

    Aim . To evaluate the role of natriuresis as a marker of the effectiveness of diuretic therapy and a predictor of adverse outcome in patients with acute decompensated heart failure (ADHF). Material and methods . The single-center prospective study included 155 patients hospitalised with ADHF in the intensive care unit (mean age 71.9±11.9 years, men 56%). All patients underwent standard physical, laboratory, and instrumental examinations in the first 24 hours, including clinical assessment of congestion, N-terminal pro-brain natriuretic peptide, lung ultrasound, venous congestion assessment according to the Venous Excess Ultrasound (VExUS) protocol, and renal function assessment (creatinine, cystatin C, and urinary albumin/creatinine). An instrumental assessment of congestion (ultrasound of the lungs, venous congestion according to the VExUS protocol), as well as an assessment of renal function (creatinine, urinary albumin/creatinine ratio) was performed after 48, 72 hours and before discharge. The starting dose of furosemide was 20-40 mg IV if patients did not receive oral diuretics, if they did, the starting dose was equal to the oral dose. After 2 hours, a quantitative assessment of sodium in urine was performed. If natriuresis level was ≥70 mmol/L, furosemide was continued at the same dose every 12 hours; if Results . Patients with natriuresis Conclusion . Natriuresis <70 mmol/L is a predictor of adverse outcomes in patients with ADHF during 1 year of follow-up and allows us to identify the most severe group of patients with a high risk of resistance to diuretic therapy.

  • Open Access

    Assessing pulmonary congestion in patients hospitalized with decompensated chronic heart failure according to lung ultrasound and remote dielectric sensing (ReDS)

    by Zh. D. Kobalava, A. F. Safarova, V. V. Tolkacheva, O. T. Zorya, F. E. Cabello Montoya, I. S. Nazarov, A. A. Lapshin, I. P. Smirnov, N. I. Khutsishvili, S. A. Galochkin, et al.

    Aim. To conduct a comparative assessment of parameters and dynamics of pulmonary congestion according to lung ultrasound and remote dielectric sensing (ReDS) in patients hospitalized with decompensated chronic heart failure (CHF).Materials and methods. The pilot single-center study included patients hospitalized with decompensated CHF. Lung ultrasound and ReDS were simultaneously performed within 24 hours from the moment of hospitalization and at discharge. Eight-zone lung ultrasound was performed with the calculation of the sum of B-lines. Pulmonary congestion was confirmed with the sum of B-lines ≥ 5. ReDS was performed according to the manufacturer’s protocol. Congestion was confirmed at the value of more than 35%. To determine ReDS interoperator variability, each patient was examined by two operators who were blind to each other’s findings with a 20–30-minute interval.Results. Thirty-five patients were included in the study: 40% (n = 14) men, the average age was 71 (65.5; 78.5) years, the median NT-proBNP was 1,379 (470; 4,277) pg / l. Hydrothorax at admission was observed in 31,4% (n = 11) of patients. The incidence of pulmonary congestion according to lung ultrasound was 57.1% (n = 20): 31.4% (n = 11) of patients had mild congestion, 22.9% (n = 8) – moderate, and 2.9% (n = 1) – severe congestion. ReDS data revealed pulmonary congestion in 62.9% (n = 22) of cases, of which 37,1% (n = 13) of cases were characterized by mild, 22.9% (n = 8) – by moderate, and 2.9% (n = 1) – by severe congestion. A moderate correlation was found between ReDS (%) and lung ultrasound (sum of B-lines) findings at admission (Spearman’s rank correlation coefficient = 0.402; p = 0.017). No correlation between the two methods was found at discharge (p = 0.613). The frequency of agreement between lung ultrasound and ReDS on signs of congestion at admission was 77.1% (p = 0.004) with an average Cohen’s Kappa coefficient (κ = 0.53). The average interoperator variability in ReDS was 9.9%.Conclusion. A moderate correlation was revealed between ReDS (%) and lung ultrasound (sum of B-lines) in detecting pulmonary congestion (Spearman’s rank correlation coefficient = 0.402; p = 0.017). No correlation between the two methods was found at discharge (p = 0.613).

  • Open Access

    Liver damage in patients hospitalized with acute decompensated heart failure, depending on the degree of glucose metabolism disorder

    by V. V. Tolkacheva, M. L. Diane, N. I. Khutsishvili, I. A. Misan, F. E. Cabello Montoya, I. S. Nazarov, I. P. Smirnov, Zh. D. Kobalava

    Aim. To study the frequency of cardiohepatic syndrome and steatosis by the value of controlled attenuation parameter (CAP), fibrosis, and their combination, depending on the degree of glucose metabolism disorder in patients with acute decompensated heart failure (ADHF).Materials and methods. The study included 280 patients (53% men, average age 70.1 ± 10.8 years) with ADHF: 72.5% of patients had a history of arterial hypertension, 60% of patients had coronary heart disease. The HbA1c test was performed in all patients to assess the status of glucose metabolism. The patients were divided into groups depending on the results obtained: at HbA1c values < 5.7%, patients were included in the group without glucose metabolism disorders, at HbA1c 5.7–6.4% – in the prediabetes group, at HbA1c ≥ 6.5% – in the type 2 diabetes group. All patients underwent a standard physical examination at admission and at discharge. Clinical and comprehensive assessments of congestion were performed – NT-proBNP, lung ultrasound, liver fibroscan with CAP, and bioelectrical impedance analysis of body composition.Results. The frequency of glucose metabolism disorders in patients hospitalized with ADHF was 57.5% (n = 161), while prediabetes was detected in 17.1% (n = 48) and type 2 diabetes – in 40.4% (n = 113) of patients. We revealed significantly higher incidence of steatosis by CAP value (69 vs. 42%, p < 0.001), fibrosis (80 vs. 64%, p < 0.001), and their combination (59 vs. 30%, p < 0.001), as well as cardiohepatic syndrome (87 vs. 61%, p < 0.001) in patients with ADHF and glucose metabolism disorders compared to individuals with ADHF without glucose metabolism disorders, respectively. The group of ADHF patients with glucose metabolism disorders and a combination of steatosis / fibrosis was characterized by more pronounced manifestations of metabolic syndrome, impaired kidney and liver function, and more pronounced manifestations (both clinical and laboratory) of congestion.Conclusion. In patients with ADHF with glucose metabolism disorders, liver function test and liver fibroscan with CAP allow for identifying the most severe group of patients with a combination of steatosis/fibrosis and pronounced congestion.

  • Open Access

    Inflammatory Cardiomyopathy as a Cause of Recurrent Ventricular Tachycardia Requiring Heart Transplant

    by Flora Elisa Cabello Montoya, Yulia Vadimovna Stavtseva, Marina Teterina, Anton Vorobiev, Zhanna Kobalava

    Introduction The most common setting for ventricular tachycardia (VT) is ischemic heart disease, in which myocardial scar tissue is the substrate for arrhythmia., However, in some myocardial diseases (i.e., myocarditis, arrhythmogenic and dilated cardiomyopathies [DCM]), electrical abnormalities can precede apparent structural changes rendering diagnosis and treatment difficult. The present study describes a case of inflammatory cardiomyopathy that appeared as a recurrent VT and required a heart transplant as the only therapeutic alternative after 20 years of the disease. […] Inflammatory [...] Introduction The most common setting for ventricular tachycardia (VT) is ischemic heart disease, in which myocardial scar tissue is the substrate for arrhythmia., However, in some myocardial diseases (i.e., myocarditis, arrhythmogenic and dilated cardiomyopathies [DCM]), electrical abnormalities can precede apparent structural changes rendering diagnosis and treatment difficult. The present study describes a case of inflammatory cardiomyopathy that appeared as a recurrent VT and required a heart transplant as the only therapeutic alternative after 20 years of the disease. […] Inflammatory

  • Open Access

    Hydration status in patients hospitalized with acute decompensated heart failure depending on the severity of glucose metabolism disorder

    by V. V. Tolkacheva, M. L. Diane, N. I. Khutsishvili, F. E. Cabello Montoya, I. S. Nazarov, I. P. Smirnov, S. A. Galochkin, Zh. D. Kobalava

    Aim. To study the hydration status according to clinical parameters and laboratory and instrumental research findings at admission and discharge in patients hospitalized with acute decompensated heart failure (ADHF), depending on the severity of glucose metabolism disorder.Materials and methods. The study included 280 patients (53% men, average age 70.1 ± 10.8 years) with ADHF. 72.5% of patients had arterial hypertension in the medical history, 60% of patients had coronary artery disease. In all patients, the level of glycated hemoglobin (HbA1c) was determined to assess the glucose metabolism status. The patients were divided into groups depending on the results obtained: at HbA1c values < 5.7%, patients were included in the group without glucose metabolism disorders, at HbA1c of 5.7–6.4% – in the prediabetes group, at HbA1c ≥ 6.5% – in the type 2 diabetes group. The patients underwent a standard physical examination at admission and at discharge, as well as a clinical and comprehensive assessment of congestion (determination of N-terminal pro B-type natriuretic peptide (NT-proBNP), lung ultrasound, liver Fibroscan testing, including calculation of a controlled attenuation parameter, bioimpedance analysis of the body).Results. The frequency of glucose metabolism disorders in patients hospitalized with ADHF was 57.5% (n = 161), while prediabetes was detected in 17.1% of patients (n = 48) and type 2 diabetes – in 40.4% (n = 113) of cases. Congestion at admission was detected in all patients. A significantly higher frequency of residual (61%) and a lower frequency of subclinical congestion (10%) were revealed in patients with ADHF and type 2 diabetes, compared to patients without glucose metabolism disorders (39% for residual congestion, 27% for subclinical congestion) and prediabetes (40% for residual congestion, 25% for subclinical congestion), respectively. There were no significant differences in the frequency of euvolemia at discharge, depending on the glucose metabolism disorder.Conclusion. Тo assess congestion phenomena at discharge, it is necessary to use clinical, laboratory, and instrumental assessments for patients with ADHF and glucose metabolism disorders. However, in patients with ADHF and prediabetes, it is preferable to focus on the laboratory and instrumental assessment of congestion, while in patients with ADHF and type 2 diabetes, both clinical and laboratory and instrumental assessment of congestion should be performed.


  • Open Access

    Assessment of Pulmonary Congestion According to Ultrasound and Remote Dielectric Sensing (ReDS) in Patients Hospitalized With Heart Failure

    by Zhanna Kobalava, Ayten Fuadovna Safarova, Veronika Tolkacheva, Flora Elisa Cabello-Montoya, Olga Tairovna Zorya, Ivan Sergeevich Nazarov, Artem Alekseevich Lapshin, Ilya Pavlovich Smirnov, Nutsiko Ivanovna Khutsishvili, Maria Vatsik-Gorodetskaya

    Background The reduction of pulmonary congestion is an essential clinical target in the management of chronic heart failure. The remote dielectric sensing (ReDS) system is a recently introduced non-invasive technology used to easily estimate the degree of lung fluid volume without any expert techniques. Objective To conduct a comparative assessment of pulmonary congestion according to ultrasound and ReDS technology in patients hospitalized with decompensation of chronic heart failure (CHF) Methods The pilot single-center study included patients hospitalized with CHF decompensation. On admission and upon discharge, lung ultrasound and ReDS technology were simultaneously performed. Ultrasound of the lungs was performed according to the protocol with an assessment of 8 zones and calculation of the sum of B-lines. Pulmonary congestion was confirmed with a sum of B-lines ≥5, ReDS congestion if >35%. A p<0.05 was considered statistically significant. Results 35 patients were included in the study; 40% (n=14) were men, the average age was 71 (65.5; 78.5) years. Pulmonary congestion, according to ultrasound, was 57.1% (n=20), and according to ReDS, 62,9% (n=22). A moderate correlation was found between ReDS (%) and lung ultrasound (sum of B-lines) upon admission (Spearman correlation coefficient = 0.402; p=0.017). There was no correlation between the two methods at discharge (p=0.613). Conclusion There was a moderate correlation between ReDS and lung ultrasound in relation to the detection of pulmonary congestion at admission.


  • Open Access

    Avaliação da Congestão Pulmonar por Ultrassom e Sensoriamento Dielétrico Remoto (ReDS) em Pacientes Hospitalizados com Insuficiência Cardíaca

    by Zhanna Kobalava, Ayten Fuadovna Safarova, Veronika Tolkacheva, Flora Elisa Cabello-Montoya, Olga Tairovna Zorya, Ivan Sergeevich Nazarov, Artem Alekseevich Lapshin, Ilya Pavlovich Smirnov, Nutsiko Ivanovna Khutsishvili, Maria Vatsik-Gorodetskaya

    Resumo Fundamento A redução da congestão pulmonar é um alvo clínico essencial no tratamento da insuficiência cardíaca crônica (ICC). O sistema de sensoriamento dielétrico remoto ( Remote Dielectric Sensing ReDS) é uma tecnologia não invasiva recentemente introduzida, usada para estimar facilmente o grau de volume de fluido pulmonar sem nenhuma técnica especializada. Objetivo Realizar uma avaliação comparativa da congestão pulmonar de acordo com a tecnologia de ultrassom e ReDS em pacientes hospitalizados com descompensação de ICC. Métodos O estudo piloto de centro único incluiu pacientes hospitalizados com descompensação de ICC. Na admissão e na alta, a ultrassonografia pulmonar e a tecnologia ReDS foram realizadas simultaneamente. A ultrassonografia dos pulmões foi realizada de acordo com o protocolo com uma avaliação de 8 zonas e cálculo da soma das linhas B. A congestão pulmonar foi confirmada com uma soma de linhas B ≥5, congestão ReDS se >35%. Um p<0,05 foi considerado estatisticamente significativo. Resultados Foram incluídos no estudo 35 pacientes; 40% (n=14) eram homens, a média de idade foi de 71 (65,5; 78,5) anos. A congestão pulmonar, segundo a ultrassonografia, foi de 57,1% (n=20), e segundo o ReDS, 62,9% (n=22). Foi encontrada correlação moderada entre o ReDS (%) e a ultrassonografia pulmonar (soma das linhas B) na admissão (coeficiente de correlação de Spearman = 0,402; p=0,017). Não houve correlação entre os dois métodos na alta (p=0,613). Conclusão Houve correlação moderada entre ReDS e ultrassonografia pulmonar em relação à detecção de congestão pulmonar na admissão.


  • Open Access

    Implementation of a “seamless” model of providing specialized medical care to patients with heart failure

    by Zhanna D. Kobalava, Veronica V. Tolkacheva, Maria V. Vatsik-Gorodetskaya, Flora E. Cabello-Montoya, Ivan S. Nazarov, Svyatoslav A. Galochkin

    Heart failure (HF) is a widespread disease and tends to increase. Despite the possibilities of modern therapy, the prognosis of patients with HF remains unfavorable. Foreign experience shows that the creation of specialized heart failure clinics improves the quality of care for patients with HF, reduces the frequency of repeated hospitalizations and death of patients. The Russian Federation has gained experience in creating such clinics, in particular, in Nizhny Novgorod, Ufa, St. Petersburg and a number of other cities. The article describes the organization of the work of the Center for HF on the basis of a multidisciplinary hospital in Moscow in period 01.11.2020-01.12.2022. The database included 2,400 patients hospitalized due to acute decompensation of chronic HF (ADCHF). The leading triggers of ADCHF in the studied patient population were an episode of atrial fibrillation/flutter (37 %), low adherence to treatment (25 %) and uncontrolled hypertension (17 %), exacerbation of concomitant diseases (11 %), infection (4 %). In 6 % of patients, the leading trigger could not be identified. The hospital stage included 950 (39.5 %) patients who, in the first 24 hours from the moment of hospitalization, underwent standard physical, laboratory and instrumental examination, including lung ultrasound, NT-proBNP, liver fibroelastometry, VEXUS protocol study, bioimpedance analysis of body composition, of which 496 (20.5 %) people passed the same studies at discharge. In the structure of patients hospitalized with ADCHF who were included in the hospital follow-up stage (n=950), patients with preserved (HFpEF) 42.5 % (n=404) and reduced ejection fraction (HFrEF) prevailed 36 % (n=342), patients with a mildly reduced (HFmrEF) ejection fraction were found in 21.5 %. 1,552 (64.5 %) patients refused additional studies and visits to the CH center, but agreed to outpatient follow-up in the form of telephone contacts. In 370 (15.4 %) patients, contact was lost after discharge. 240 (10 %) patients actively visit the HF center with a comprehensive assessment of congestion and correction of therapy at each visit. Conclusion. There are two stages in the treatment of patients with chronic HF. The first stage is hospital, the second one is outpatient. It is important not to make omissions in the prescribed drug therapy, which can lead to a fatal outcome. To this end, it is necessary to introduce a “seamless” model of medical care for patients with chronic HF, when the patient comes under the supervision of a multidisciplinary team that carries out timely monitoring.


  • Open Access

    Prognostic value of periprocedural dynamics of left ventricular ejection fraction and subclinical pulmonary congestion in patients with myocardial infarction

    by Tatiana M. Timofeeva, Zhanna D. Kobalava, Ayten F. Safarova, Flora Elisa Cabello Montoya

    Aim. To assess the joint prognostic value of periprocedural dynamics of the left ventricular ejection fraction (PPD of LVEF) and subclinical pulmonary congestion during lung stress ultrasound in patients with first acute myocardial infarction (AMI) and percutaneous coronary intervention (PCI) in relation to the development of heart failure (HF) in the postinfarction period. Materials and methods. Our prospective, single-centre, observational study included 105 patients with a first MI with no HF in the anamnesis and successful PCI. All patients underwent standard clinical and laboratory tests, NT-proBNP level assessment, echocardiography, lung stress ultrasound with a 6-minute walk test. All patients had no clinical signs of heart failure at admission and at discharge. Criteria for PPD of LV EF: improvement in LV EF50%; ∆LV EF more than 5%, but LV EF50%. According to the results of lung stress ultrasound, pulmonary congestion was diagnosed: mild (24 B-lines), moderate (59 B-lines) and severe (10 B-lines). The end point was hospitalization for HF for 2.5 years. Results. Upon admission, LV EF of 50% or more was registered in 45 patients (42.9%). Positive PPD was registered in 31 (29.5%) patients. After stress ultrasound of the lungs, 20 (19%) patients had mild subclinical pulmonary congestion, 38 (36%) moderate and 47 (45%) severe according to the criteria presented. During the observation period, patients with no PPD of LVEF were significantly more likely to be hospitalized for the development of HF (in 44.4% of cases) compared with patients with positive PPD (in 15.2% of cases) and with initial LV EF50% (in 13.4% of cases; p=0.005). When performing logistic regression analysis, the best predictive ability was found in the combination of the absence of PPD of LV EF and the sum of B-lines 10 on exercise (relative risk 7.45; 95% confidence interval 2.5521.79; p0.000). Conclusion. Evaluation of the combination of PPD of LV EF and the results of stress lung ultrasound at discharge in patients with first AMI and successful PCI with no HF in anamnesis allows us to identify a high-risk group for the development of HF in the postinfarction period.


  • Open Access

    Prognostic value of the inferior vena cava diameter, lung ultrasound, and the NT-proBNP level in patients with acute decompensated heart failure and obesity

    by Zh. D. Kobalava, F. E. Cabello Montoya, A. F. Safarova, V. V. Tolkacheva, A. A. Abramov

    Aim. To evaluate the clinical and prognostic value of the inferior vena cava (IVC) diameter, the sum of B-lines according to lung ultrasound (LUS), and the NT-proBNP level in patients with acute decompensated heart failure (ADHF) and obesity.Materials and methods. A single-center, prospective study included 162 patients with ADHF (66% men, age 68 ± 12 years, left ventricular ejection fraction (LVEF) 44 (35; 54)%, median level of NT-proBNP 4,246 (1,741; 6,837) pg / ml). 27.8% of patients were overweight, 55% of patients had obesity. Upon admission, all patients underwent a standard clinical and laboratory examination, including lung ultrasound with the calculation of the sum of B-lines, IVC ultrasound, and determination of the NT-proBNP level.Results. Obese patients had a smaller sum of B-lines according to lung ultrasound than overweight patients and those with normal weight [33 (21–51); 38 (27–54), and 42 (30–58), respectively; p = 0.002] and a lower level ofNT-proBNP [3,404 (1,630; 5,516); 4,458 (2,697; 5,969); 5,085 (2,871; 7,351) pg / ml, respectively, p = 0.013]. TheIVC diameter did not differ significantly depending on body mass index (BMI): with obesity – 2.3 (1.9–2.8) cm, with overweightness – 2.3 (1.9–2.8) cm, and with normal weight – 2.2 (1.8–2.4) mm, p = 0.324.According to the multivariate Cox regression analysis, the sum of B-lines > 7 at discharge (hazard ratio (HR) 8.90, 95% confidence interval (CI) 2.03–38.30, p = 0.003) and IVC > 2.4 cm at admission (HR 5.42, 95% CI 1.04–28.13, p = 0.045) were independently associated with a higher risk of 12-month mortality from cardiovascular disease.Conclusion. Therefore, lung ultrasound with B-line quantification and assessment of the IVC diameter may be useful in obese patients with ADHF to stratify the risk of 12-month mortality from cardiovascular disease.